Sort   by:  
 Page size 
UnknownPhase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma.
Not available
S-EPMC5791841 | biostudies-literature
UnknownCediranib for metastatic alveolar soft part sarcoma.
Not available
S-EPMC3677840 | biostudies-literature
UnknownNivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial.
Not available
S-EPMC4806782 | biostudies-literature
UnknownDurable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study.
Not available
S-EPMC10909726 | biostudies-literature
UnknownUse of bacterial whole-genome sequencing to investigate local persistence and spread in bovine tuberculosis.
Not available
S-EPMC4773590 | biostudies-literature
UnknownEvaluating the impact of doxorubicin preconditioning on the efficacy of inhaled recombinant human IL-15 immunotherapy in dogs with pulmonary metastasis.
Not available
S-EPMC12484353 | biostudies-literature
UnknownComprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma.
Not available
S-EPMC8127353 | biostudies-literature
UnknownThe Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.
Not available
S-EPMC12770936 | biostudies-literature
UnknownFDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy.
Not available
S-EPMC9197942 | biostudies-literature
UnknownMolybdenum Availability Is Key to Nitrate Removal in Contaminated Groundwater Environments.
Not available
S-EPMC4495186 | biostudies-literature
Sort   by:  
 Page size